Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions

Bone metastasis remains a major cause of mortality and morbidity in breast cancer. Therefore, there is an urgent need to better select high-risk patients in order to adapt patient’s treatment and prevent bone recurrence. Here, we found that integrin alpha5 (ITGA5) was highly expressed in bone metast...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantano, Francesco, Croset, Martine, Driouch, Keltouma, Bednarz-Knoll, Natalia, Iuliani, Michele, Ribelli, Giulia, Bonnelye, Edith, Wikman, Harriet, Geraci, Sandra, Bonin, Florian, Simonetti, Sonia, Vincenzi, Bruno, Hong, Saw See, Sousa, Sofia, Pantel, Klaus, Tonini, Giuseppe, Santini, Daniele, Clézardin, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892344/
https://www.ncbi.nlm.nih.gov/pubmed/33420367
http://dx.doi.org/10.1038/s41388-020-01603-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892344/
https://www.ncbi.nlm.nih.gov/pubmed/33420367
http://dx.doi.org/10.1038/s41388-020-01603-6

Ejemplares similares